Asset Entities ASST Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Asset Management | $1.35M-9.9% | $1.5M-64.4% | $4.19M+195% | $1.42M+37.5% | $1.04M+5.2% | |
| Corporate & Other | $43K+153% | $17K-39.3% | $28K— | $0— | $0— | |
| Medical Device | $1.37M— | —— | —— | $0— | —— | |
| Total revenues by Product | ||||||
| Investment advisory fees | $1.35M-9.9% | $1.5M-64.3% | $4.19M+196% | $1.42M+37.2% | $1.03M+8.6% | |
| Medical device revenues | $1.37M— | —— | —— | $0— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Asset Entities break its business down?
- Asset Entities (ASST) reports total revenues by business across 3 parts — Asset Management, Corporate & Other and Medical Device. Each is extracted from the segment footnotes and tracked over time.
- Where does Asset Entities's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Asset Entities's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
